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Dear Ms. Erwin:
This is the final report on Joint Research Interchange (NCC2-
5011) "Construction of a Specialized Cloning Strain of E.. coli for the
Nitrate Reductase Genes of Haloferax denitrificans." Originally the
award was 11/I/93-10/31/95, but there were no-cost extensions
made, because of a year Sabbatical at the Pasteur Institue in Paris
and other leaves of 3 months each at the Pasteur institute, during
which work could not be done on this project, which extended the
closing date to 10/30/98.
I shall begin with a brief discussion of the goal and rationale of
the project as originally envisioned by the collaborative
investigators, myself and Dr. Lawrence Hochstein.
Dr. Hochstein worked for many years on the biochemistry and
enzymology of haiophilic bacteria. At the point that this project
commenced he was very interested in trying to clone the nitrate
reductase gene(s) of Haloferax denitrificans. Attendant to this
eventual pursuit was the need to satisfy certain prerequisites
specific to cloning this gene(s) of this organism. I will not enumerate
all of those considerations, but simply point out that on carefully
evaluating the goal of the project the need for a specialized cloning
strain became evident. This was the origin of the collaborative
project for which this is the final report.
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It was _easonably clear that the cloning strain would have to
have certain specific characteristics over and above what is
commonly the case in the readily available cloning strains. This
necessitated constructing this strain. Additionally, it seemed at the
time that the only feasable approach to the cloning operation when
undertaken would be a two tiered system. The strain to be
constructed would in the first stage, as is commonly the case in
cloning operations, be designed simply to maximize selection for
clones with inserts of halophile DNA. Then in the second stage it
would be designed to attempt to complement strains of E. coil
possessing insertional inactivation (a functional deletion) of the
nitrate reductase genes, with the putative cloned nitrate reductase
gene(s) of Haloferax denitrificans.
I am happy to report that we have succeeded in constructing
just such a strain and therefore the goal of the project has been
successfully completed. Unfortunately, Dr. Hochstein retired last
year and I have now retired as well, therefore the cloning project
cannot be pursued by either of us.
The specialized cloning strain has the following characteristics:
1. It has the lac selection system common to many cloning
systems. The system consists of a deletion of the lac genes on the
chromosome. The strain also contains F'(AlacZM15). The sequences
coding for the AlacZM15 complementing lac fragments must be
introduced on the cloning plasmid and should contain several cloning
sites within those sequences. This permits the blue-white colony
differentiation on x-gal plates for clones containing insertions of the
DNA one wants to clone.
2. There is an insertional inactivation of one of the nitrate
reductase genes on the chromosome to allow for a colorometric test
of functional complementation, distinguishing between nitrate
reductase negative and positive organisms by differences in colony
color. This permits the rapid screening of clones of DNA sequences
represenlin_ the xvhole chlomosome of Haloferax denitrificans for
the nitxatc _cducta_e gene(s),
3. This strain has an unusual array of antibiotic resistances
which makes it essentially foolproof against any conceivable
conta,ninants. It is resistant to streptomycin 2001.tg/ml, ampicillin
lOOug/_tl (if pUC cloning plasmids or their derivatives are used. Also
one could use other cloning plasmids with other antibiotic resistances
provided they contain sequences complementing the AlacZM15
complementing sequences within which are the cloning sites, and
tetracycline 100t.tg/ml. Of particular note is the tetracyclin
resistance. The normal resistance level for most bacteria to
tetracycline is 10-15 /,g/ml. A resistance level of 100!ag/ml virtually
assures that nothing but this specialized cloning strain will grow on
the selection plates. With these characteristics the strain is indeed
specialized for the intended goal.
However. as previously mentioned, with the retirement of Dr.
Hochestein prior to the last no-cost extension and now my retirment,
this will conclude this collaborative research project.
This strain will be made available in accordance with your
instructiot_.
In addition I v,,ili be at the Pasteur Institute beginning March
2. My e-mail address there is:
e johnson@ pasteur.fr
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France
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